Developer docs
API playgroundTry for free, no card

Search company profiles

Lidco

Full company profile

uuid003l895

Namestring
Lidco
Legal namestring
Masimo Corporation
Websiteurl
lidco.com
Company typeenum
Private
Founded yearint
1991
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hemodynamic monitoring, cardiac output monitoring, patient monitoring devices, critical care monitoring, perioperative monitoring
Industry2 codes
1Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
CodeHLAHAFAIPrimaryYes
2Medical-Grade Device Connectivity & Device Management (MDM)
CodeHLACAFAGPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Hemodynamic Monitoring Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Hardware Sales
TypeHardware Sales
Description

LiDCO generates revenue through the sale of hemodynamic monitoring equipment (monitors) and associated components. The system uses existing arterial line and blood pressure transducer infrastructure, eliminating need for additional disposables. Revenue likely follows medical device industry model with equipment placement and recurring consumables/reagents.

masimo.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

LiDCO sells the LiDCO Hemodynamic Monitoring System, a medical device that provides beat-to-beat advanced hemodynamic monitoring for high-acuity care settings such as operating rooms and ICUs. The system uses the proprietary PulseCO algorithm to convert blood pressure waveform data from existing arterial lines and transducers into hemodynamic parameters (Stroke Volume, Cardiac Output, Systemic Vascular Resistance, Oxygen Delivery, Stroke Volume Variation, and Pulse Pressure Variation), scaled to each patient's demographics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 20%+ reduction in postoperative complications
+3 more records
Product overview1 text field

Lidco offers a single unified product: the LiDCO Hemodynamic Monitoring System. This system provides continuous hemodynamic monitoring by connecting to existing arterial lines and blood pressure transducers via the invasive blood pressure output port on vital signs monitors. The device displays beat-to-beat parameters including Stroke Volume (SV), Cardiac Output (CO), Systemic Vascular Resistance (SVR), Oxygen Delivery (DO2), Stroke Volume Variation (SVV), and Pulse Pressure Variation (PPV), using the proprietary PulseCO algorithm to convert blood pressure waveforms into actionable hemodynamic data.

Product and service1 record
1LiDCO Hemodynamic Monitoring System
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierParent_CompanyTypeOthers
Description

Masimo (parent company of LiDCO) was acquired by Danaher Corporation. LiDCO is now part of the Danaher portfolio of life sciences and diagnostics companies. Danaher operates under a decentralized operating company structure.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dräger provides anesthesia and patient monitoring systems used in OR/ICU, with hemodynamic parameter capabilities — a broad incumbent selling integrated solutions where LiDCO typically sits as an add-on module.

TypeDirect peer
Description

ICU Medical offers hemodynamic monitoring through its Hospira/Power Injection acquired assets and has been expanding in critical care monitoring, competing head-to-head with LiDCO in hemodynamic parameter measurement.

TypeBroad incumbent
Description

Nihon Kohden is a major patient monitoring company offering hemodynamic parameters in its bedside monitors — a broad incumbent with significant global reach in the same OR/ICU category LiDCO serves.

TypeDirect peer
Description

Edwards Lifesciences is the dominant hemodynamic monitoring competitor with its FloTrac/Vigileo and ClearSight systems, offering continuous cardiac output monitoring in OR/ICU settings — directly overlapping LiDCO's core use case.

TypeEmerging player
Description

Cheetah Medical provides non-invasive hemodynamic monitoring (NICOM/Starling SV) targeting fluid responsiveness in OR/ICU — overlapping with LiDCO's SVV/PPV-based approach but using a different sensor modality.

TypeBroad incumbent
Description

Getinge's Maquet and Atrium brands supply OR and ICU equipment including hemodynamic monitoring modules, competing with LiDCO via capital equipment sales to the same hospital departments.

TypeOthers
Description

Masimo is LiDCO's direct parent and provides adjacent patient monitoring technologies (SET pulse oximetry, SedLine brain monitoring, rainbow Pulse CO-Oximetry) sold through the same hospital sales channels that distribute LiDCO.

TypeBroad incumbent
Description

GE Healthcare's CARESCAPE patient monitoring platform includes hemodynamic parameters and dominates OR/ICU capital purchasing — a broad incumbent competing with LiDCO via bundled monitoring solutions.

TypeBroad incumbent
Description

Philips offers integrated hemodynamic monitoring within its IntelliVue and patient monitoring portfolios, leveraging a broad hospital footprint and enterprise sales channels that compete with LiDCO in the same high-acuity buying decisions.

TypeEmerging player
Description

Osypka Medical offers non-invasive and invasive hemodynamic monitoring solutions (AESCULON, ICON) targeting cardiac output measurement — an emerging competitor with overlapping OR/ICU applications to LiDCO.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lidco

Hemodynamic Monitoring Deviceslidco.com

Lidco firmographics

Firmographics
Name
Lidco
Legal name
Masimo Corporation
Website
https://lidco.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Lidco industry classification

Industry
Product category
Hemodynamic Monitoring Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
akta.pro secondary industry
Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

  • Hemodynamic monitoring
  • Cardiac output monitoring
  • Patient monitoring devices
  • Critical care monitoring
  • Perioperative monitoring

Where Lidco is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Lidco business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Medical Device Hardware Sales: LiDCO generates revenue through the sale of hemodynamic monitoring equipment (monitors) and associated components. The system uses existing arterial line and blood pressure transducer infrastructure, eliminating need for additional disposables. Revenue likely follows medical device industry model with equipment placement and recurring consumables/reagents.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Lidco product offering

Product offering

Core offering

LiDCO sells the LiDCO Hemodynamic Monitoring System, a medical device that provides beat-to-beat advanced hemodynamic monitoring for high-acuity care settings such as operating rooms and ICUs. The system uses the proprietary PulseCO algorithm to convert blood pressure waveform data from existing arterial lines and transducers into hemodynamic parameters (Stroke Volume, Cardiac Output, Systemic Vascular Resistance, Oxygen Delivery, Stroke Volume Variation, and Pulse Pressure Variation), scaled to each patient's demographics.

Product overview

Lidco offers a single unified product: the LiDCO Hemodynamic Monitoring System. This system provides continuous hemodynamic monitoring by connecting to existing arterial lines and blood pressure transducers via the invasive blood pressure output port on vital signs monitors. The device displays beat-to-beat parameters including Stroke Volume (SV), Cardiac Output (CO), Systemic Vascular Resistance (SVR), Oxygen Delivery (DO2), Stroke Volume Variation (SVV), and Pulse Pressure Variation (PPV), using the proprietary PulseCO algorithm to convert blood pressure waveforms into actionable hemodynamic data.

Differentiator

Problem solved

Functional benefit

Products and services

  • LiDCO Hemodynamic Monitoring System

Quantifiable outcome

  • 20%+ reduction in postoperative complications
  • +3 more outcomes

Companies that use Lidco

Customer profile

Segments1 record

Ideal customer profiles1 record

Lidco technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Lidco partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Danaherparent_companyOthersMasimo (parent company of LiDCO) was acquired by Danaher Corporation. LiDCO is now part of the Danaher portfolio of life sciences and diagnostics companies. Danaher operates under a decentralized operating company structure.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Lidco competitors and assessment

Company assessment

Broad incumbents

  • Drägerwerk: Dräger provides anesthesia and patient monitoring systems used in OR/ICU, with hemodynamic parameter capabilities — a broad incumbent selling integrated solutions where LiDCO typically sits as an add-on module.
  • Nihon Kohden: Nihon Kohden is a major patient monitoring company offering hemodynamic parameters in its bedside monitors — a broad incumbent with significant global reach in the same OR/ICU category LiDCO serves.
  • Getinge: Getinge's Maquet and Atrium brands supply OR and ICU equipment including hemodynamic monitoring modules, competing with LiDCO via capital equipment sales to the same hospital departments.
  • GE Healthcare: GE Healthcare's CARESCAPE patient monitoring platform includes hemodynamic parameters and dominates OR/ICU capital purchasing — a broad incumbent competing with LiDCO via bundled monitoring solutions.
  • Philips Patient Monitoring: Philips offers integrated hemodynamic monitoring within its IntelliVue and patient monitoring portfolios, leveraging a broad hospital footprint and enterprise sales channels that compete with LiDCO in the same high-acuity buying decisions.

Direct peers

  • ICU Medical: ICU Medical offers hemodynamic monitoring through its Hospira/Power Injection acquired assets and has been expanding in critical care monitoring, competing head-to-head with LiDCO in hemodynamic parameter measurement.
  • Edwards Lifesciences: Edwards Lifesciences is the dominant hemodynamic monitoring competitor with its FloTrac/Vigileo and ClearSight systems, offering continuous cardiac output monitoring in OR/ICU settings — directly overlapping LiDCO's core use case.

Emerging players

  • Cheetah Medical: Cheetah Medical provides non-invasive hemodynamic monitoring (NICOM/Starling SV) targeting fluid responsiveness in OR/ICU — overlapping with LiDCO's SVV/PPV-based approach but using a different sensor modality.
  • Osypka Medical: Osypka Medical offers non-invasive and invasive hemodynamic monitoring solutions (AESCULON, ICON) targeting cardiac output measurement — an emerging competitor with overlapping OR/ICU applications to LiDCO.

Others

  • Masimo Corporation: Masimo is LiDCO's direct parent and provides adjacent patient monitoring technologies (SET pulse oximetry, SedLine brain monitoring, rainbow Pulse CO-Oximetry) sold through the same hospital sales channels that distribute LiDCO.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Lidco social profiles

Digital presence

Lidco financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lidco leadership team

Management profile

Number of profiles

Profiles1 record

Lidco funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lidco M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lidco

What does Lidco do?

LiDCO sells the LiDCO Hemodynamic Monitoring System, a medical device that provides beat-to-beat advanced hemodynamic monitoring for high-acuity care settings such as operating rooms and ICUs. The system uses the proprietary PulseCO algorithm to convert blood pressure waveform data from existing arterial lines and transducers into hemodynamic parameters (Stroke Volume, Cardiac Output, Systemic Vascular Resistance, Oxygen Delivery, Stroke Volume Variation, and Pulse Pressure Variation), scaled to each patient's demographics.

Is Lidco a public or private company?

Lidco is a private company. It is classified as corporate owned and is currently operating.

When was Lidco founded?

Lidco was founded in 1991. It employs 51 to 100 people.

Where is Lidco based?

Lidco is headquartered in London, United Kingdom, in the Europe region.

How does Lidco make money?

One revenue line is on record: medical Device Hardware Sales.

Who are Lidco's main competitors?

Broad incumbents on record are Drägerwerk, Nihon Kohden, Getinge, GE Healthcare and Philips Patient Monitoring. Direct peers are ICU Medical and Edwards Lifesciences. Emerging players are Cheetah Medical and Osypka Medical. Masimo Corporation is listed as an others.

Does Lidco have an API?

No public API is recorded for Lidco.

What industry is Lidco in?

Lidco's product category is Hemodynamic Monitoring Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLACAFAG, Medical-Grade Device Connectivity & Device Management (MDM). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePulse Oximeter Market had reached Revenue of US$ 2.3 Bn in 2021 and at an Expected CAGR of 7.6% the Market is Estimated to Cross worth of US$ 5.1 Bn by year 2032-end | Future Market Insights, Inc.Future Market Insights published a report estimating the global pulse oximeter market at US$2.3 billion in 2021, projected to reach US$5.1 billion by 2032 with a CAGR of 7.6% during 2022-2032. The COVID-19 pandemic served as a key growth driver, with US sales of fingerprint pulse oximeters increasing 527% during the week of January 2020 and Flipkart reporting a 23-fold increase in demand. The competitive landscape section highlights several product launches and partnerships, including Smart Meter's iPulseOx, DetelPro's Oxy10, Masimo's acquisition of LiDCO, and collaborations between Masimo and Royal Philips.GlobeNewswireForm 8.3 - [LiDCO Group plc - Opening Declaration] - (HHL)Hargreave Hale Limited disclosed an opening position in LiDCO Group plc on 3 November 2020, holding 3,085,109 ordinary shares representing 1.2635% of the company. No dealings or other arrangements were disclosed.PR NewswireThe hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4%The global hemodynamic monitoring systems market is projected to grow from USD 857.8 million in 2018 to USD 1,167.4 million by 2023 at a CAGR of 6.4%, driven by technological advancements, rising cardiovascular disease prevalence, and increasing government focus on critical care infrastructure, though risks associated with invasive monitoring may restrain growth to some extent. The Asia Pacific region is expected to witness the highest growth during the forecast period, with Japan, India, China, Australia, and Singapore identified as key emerging markets. Key players in the market include Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc, Cheetah Medical, Deltex Medical Group Plc., ICU Medical, Osypka Medical GmbH, CareTaker Medical, CNSystems, NI Medical, and Uscom.PR NewswireResearch and Markets - Global Hemodynamic Monitoring Market 2016-2020 - Key Vendors are Edwards Lifesciences, ICU Medical, LiDCO & PULSION Medical Systems SEResearch and Markets has released its Global Hemodynamic Monitoring Market 2016-2020 report, projecting the market to grow at a compound annual growth rate of 6.44% during the forecast period. The report identifies Edwards Lifesciences, ICU Medical, LiDCO, and PULSION Medical Systems SE as the key vendors operating in this market. Key drivers for market growth include increasing demand for disease treatment and critical care, government funding programs such as the NIH's Vascular Interventions/Innovations and Therapeutic Advances Program, and the susceptibility of infants, women, and older populations to cardiac conditions.